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Efficacy of N-acetyl cysteine (NAC) in dyspeptic patients and negative Helicobacter pylori 
infection  
Abstract 
Background & Objectives: Functional dyspepsia is a common complaint with symptoms like 
bloating or epigastric pain, early satiation, heart burn and nausea in the absence of underlying 
organic or metabolic disease. N-acetyl cysteine (NAC) has multiple potential effects and has 
been used for treatment of different diseases. In this study we evaluated the efficacy of NAC in 
improving the dyspepsia symptoms in dyspeptic patients with H. pylori negative results.  
Methods: In this randomized clinical trial, 85 patients with functional dyspepsia without H. 
pylori infection underwent treatment with proton pump inhibitor (PPI) (pantoprazole 40 mg) 
daily with (n=41) or without (n=44) NAC 600 mg twice a day for eight weeks. Patients’ clinical 
symptoms and change in the severity of dyspepsia symptoms were compared between groups.            
Results: Common symptoms were epigastric pain and bloating. Intervention group compared to 
control group had significantly more cases with retrosternal burn and blotching and less early 
satiation. In both intervention and control groups dyspepsia severity was significantly reduced 
from 5.26±2.06 and 4.68±2.81 to 1.87±1.38 and 2.22±2.04, respectively (p<0.001). The percent 
of reduction in dyspepsia severity in intervention group was significantly higher than control 
group (-66.25±23.44% vs. -50.14±35.02%, p=0.01).       
Conclusion: PPI is effective in the treatment of functional dyspepsia and NAC as an adjuvant is 
a safe treatment that could increase the response rate and treatment efficacy in these patients.               
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